MAPT and Alzheimer disease: It was reported that insulin signaling dysfunction correlated with an increased accumulation of Aβ, phosphorylated tau, reactive oxygen/nitrogen species, neuroinflammation and cognitive impairment in the brains of AD patients and animal models54, 55.